Sierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019

Press/Media: Press / Media

PeriodNov 6 2019 → Nov 8 2019

Media coverage

20

Media coverage

  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletBioSpace
    CountryUnited States
    Date11/8/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletPR Newswire
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletCanada NewsWire
    CountryCanada
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletCanada NewsWire
    CountryCanada
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletPR Newswire
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletPR Newswire
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleTo Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletMarket News Publishing
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletIndia Pharma News
    CountryIndia
    Date11/6/19
    PersonsRuben Mesa
  • TitleTo Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletMarket News Publishing
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletCrwe World
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletProfitQuotes.com
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletTickerTech.com
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletCanadian Life Sciences Database
    CountrySwitzerland
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletNews 9
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletChannel 8 Eyewitness News
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletErie News Now
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletWFMJ 21 - TV
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletWICZ
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletWBOC TV 16
    CountryUnited States
    Date11/6/19
    PersonsRuben Mesa
  • TitleSierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
    Media name/outletCentral Charts
    CountryFrance
    Date11/6/19
    PersonsRuben Mesa